Harminder Singh1, Ritu Bala2, Kamalpreet Kaur3. 1. Associate Professor, Department of Pharmacology, G.G.S. Medical College , Faridkot, Punjab. India . 2. 3nd year Post-graduate Resident, Department of Pharmacology, G.G.S. Medical College , Faridkot, Punjab. India . 3. Assistant Professor, Department of Pharmacology, G.G.S. Medical College , Faridkot, Punjab. India .
Abstract
OBJECTIVE: This is a prospective, randomized study designed to demonstrate the efficacy of three study drugs (Levosulpiride, Domperidone and Metoclopramide) in Functional Dyspepsia. Subject recruitment was done from medicine outpatient department of the teaching hospital from June 2013 to November 2013. MATERIALS AND METHODS: The data collection was performed by the Short-Form Leeds Dyspepsia Questionnaire (SF-LDQ) question instrument for assessing the dyspeptic symptoms of functional dyspepsia in patients enrolled in the study were assessed at base line (Prior to initiation of therapy) and at the next 4 weeks on a 5-point scale. RESULT: Among 120 patients 113 patients completed this study in three groups (G-1 Levosulpiride 40 patients, G-2 Domperidone 35 patients and G-3 Metoclopramide 38 patients) were followed up. Female gender was dominated (75), occupation wise most of patients belong to laborer (49) class. Highly significant improvement in symptoms scale was noticed in G-1 Levosulpiride 40 patients' group. CONCLUSION: Functional Gastrointestinal disorders are not serious ailments but have a key impact on quality of life. overall dyspeptic symptom relief rates were significantly high in the Levosulpiride group (p<0.004) as compare to Domperidone and Metoclopramide groups. A proper understanding of disease process by health care personnel and by sufferer is obligatory to enhance the quality of life and daunting the self/over the counter medication in this condition.
RCT Entities:
OBJECTIVE: This is a prospective, randomized study designed to demonstrate the efficacy of three study drugs (Levosulpiride, Domperidone and Metoclopramide) in Functional Dyspepsia. Subject recruitment was done from medicine outpatient department of the teaching hospital from June 2013 to November 2013. MATERIALS AND METHODS: The data collection was performed by the Short-Form Leeds Dyspepsia Questionnaire (SF-LDQ) question instrument for assessing the dyspeptic symptoms of functional dyspepsia in patients enrolled in the study were assessed at base line (Prior to initiation of therapy) and at the next 4 weeks on a 5-point scale. RESULT: Among 120 patients 113 patients completed this study in three groups (G-1 Levosulpiride 40 patients, G-2 Domperidone 35 patients and G-3 Metoclopramide 38 patients) were followed up. Female gender was dominated (75), occupation wise most of patients belong to laborer (49) class. Highly significant improvement in symptoms scale was noticed in G-1 Levosulpiride 40 patients' group. CONCLUSION: Functional Gastrointestinal disorders are not serious ailments but have a key impact on quality of life. overall dyspeptic symptom relief rates were significantly high in the Levosulpiride group (p<0.004) as compare to Domperidone and Metoclopramide groups. A proper understanding of disease process by health care personnel and by sufferer is obligatory to enhance the quality of life and daunting the self/over the counter medication in this condition.
Entities:
Keywords:
Gastrointestinal disorders; Prokinetic; Quality of life
Authors: H Miwa; S Hirai; A Nagahara; T Murai; T Nishira; S Kikuchi; Y Takei; S Watanabe; N Sato Journal: Aliment Pharmacol Ther Date: 2000-03 Impact factor: 8.171
Authors: G R Corazza; F Biagi; O Albano; G Bianchi Porro; R Cheli; G Mazzacca; F Miglio; R Naccarato; D Quaglino; C Surrenti; G Verme; G Gasbarrini Journal: Ital J Gastroenterol Date: 1996 Jul-Aug
Authors: C Mansi; V Savarino; S Vigneri; D Perilli; P Melga; L Sciabà; D De Martini; G S Mela Journal: Am J Gastroenterol Date: 1995-11 Impact factor: 10.864
Authors: Nunzio Ranaldo; Giuseppe Losurdo; Andrea Iannone; Mariabeatrice Principi; Michele Barone; Massimo De Carne; Enzo Ierardi; Alfredo Di Leo Journal: Cell Death Dis Date: 2017-09-07 Impact factor: 8.469
Authors: Mansij Biswas; Kritarth Naman Mithileshwar Singh; Yashashri C Shetty; Paresh G Koli; Sushrut Ingawale; Shobna J Bhatia Journal: Indian J Med Res Date: 2019-06 Impact factor: 2.375